• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Case of acute-onset type 1 diabetes induced by long-term immunotherapy with nivolumab in a patient with mucosal melanoma.

作者信息

Maekawa Takeo, Okada Kenta, Okada Hirofumi, Kado Soichiro, Kamiya Koji, Komine Mayumi, Murata Satoru, Oka Kiyonori, Ishibashi Shun, Ohtsuki Mamitaro

机构信息

Department of Dermatology, Jichi Medical University, Tochigi, Japan.

Division of Endocrinology and Metabolism, Department of Internal Medicine, Jichi Medical University, Tochigi, Japan.

出版信息

J Dermatol. 2019 Dec;46(12):e463-e464. doi: 10.1111/1346-8138.15061. Epub 2019 Aug 22.

DOI:10.1111/1346-8138.15061
PMID:31436330
Abstract
摘要

相似文献

1
Case of acute-onset type 1 diabetes induced by long-term immunotherapy with nivolumab in a patient with mucosal melanoma.黏膜黑色素瘤患者长期使用纳武单抗免疫治疗诱发急性起病的1型糖尿病病例。
J Dermatol. 2019 Dec;46(12):e463-e464. doi: 10.1111/1346-8138.15061. Epub 2019 Aug 22.
2
Case of type 1 diabetes associated with less-dose nivolumab therapy in a melanoma patient.一名黑色素瘤患者中1型糖尿病与低剂量纳武利尤单抗治疗相关的病例。
J Dermatol. 2017 May;44(5):605-606. doi: 10.1111/1346-8138.13486. Epub 2016 Jun 23.
3
Type 1 diabetes in a melanoma patient treated with ipilimumab after nivolumab.一名黑色素瘤患者在接受纳武单抗治疗后使用伊匹单抗治疗时发生1型糖尿病。
J Dermatol. 2018 Oct;45(10):e289-e290. doi: 10.1111/1346-8138.14331. Epub 2018 Apr 18.
4
Dramatic effect of nivolumab against melanoma and immune-related liver toxicity: A detailed histopathological and immunohistochemical analysis of nivolumab-induced liver toxicity.纳武单抗治疗黑色素瘤的显著疗效及免疫相关肝毒性：纳武单抗诱导肝毒性的详细组织病理学和免疫组化分析
J Dermatol. 2019 May;46(5):e182-e183. doi: 10.1111/1346-8138.14710. Epub 2018 Nov 26.
5
An update on the safety of nivolumab for the treatment of advanced melanoma.纳武利尤单抗治疗晚期黑色素瘤的安全性更新。
Expert Opin Drug Saf. 2020 Apr;19(4):409-421. doi: 10.1080/14740338.2020.1757068.
6
Development of Poliosis Following Checkpoint Inhibitor Treatment for Cutaneous Melanoma.黑色素瘤皮肤癌治疗后出现的白毛症。
Ophthalmic Plast Reconstr Surg. 2019 Sep/Oct;35(5):e121-e122. doi: 10.1097/IOP.0000000000001451.
7
Pseudoprogression with subsequent complete response and severe thrombocytopenia to checkpoint inhibitor immunotherapy in a patient with advanced mucosal melanoma of the sinonasal cavity.鼻腔鼻窦黏膜黑色素瘤晚期患者接受检查点抑制剂免疫治疗后出现假性进展伴随后完全缓解和严重血小板减少症。
Anticancer Drugs. 2018 Oct;29(9):914-918. doi: 10.1097/CAD.0000000000000664.
8
Onset of fulminant type 1 diabetes mellitus following hypophysitis after discontinuation of combined immunotherapy. A case report.停用免疫联合疗法后发生垂体炎导致暴发性 1 型糖尿病：1 例报告。
J Diabetes Investig. 2021 Dec;12(12):2263-2266. doi: 10.1111/jdi.13604. Epub 2021 Jul 3.
9
Nasal mucosal melanoma as a cause of epistaxis.鼻黏膜黑色素瘤作为鼻出血的一个病因。
BMJ Case Rep. 2019 Jul 12;12(7):e228640. doi: 10.1136/bcr-2018-228640.
10
New onset diabetes with ketoacidosis following nivolumab immunotherapy: A case report and review of literature.纳武利尤单抗免疫治疗后新发伴酮症酸中毒的糖尿病：病例报告及文献复习。
J Oncol Pharm Pract. 2021 Apr;27(3):716-721. doi: 10.1177/1078155220943949. Epub 2020 Jul 28.

引用本文的文献

1
Successful treatment of nivolumab and ipilimumab triggered type 1 diabetes by using sodium-glucose transporter 2 inhibitor: a case report and systematic review.成功治疗纳武利尤单抗和伊匹单抗引发的 1 型糖尿病：病例报告和系统评价。
Front Public Health. 2023 Dec 1;11:1264056. doi: 10.3389/fpubh.2023.1264056. eCollection 2023.
2
Diabetes mellitus induced by immune checkpoint inhibitors: type 1 diabetes variant or new clinical entity? Review of the literature.免疫检查点抑制剂引起的糖尿病：1 型糖尿病变异型还是新的临床实体？文献复习。
Rev Endocr Metab Disord. 2021 Jun;22(2):337-349. doi: 10.1007/s11154-020-09618-w. Epub 2021 Jan 6.